Rezolute, Inc. Files 8-K with Financials
Ticker: RZLT · Form: 8-K · Filed: Apr 28, 2025 · CIK: 1509261
| Field | Detail |
|---|---|
| Company | Rezolute, Inc. (RZLT) |
| Form Type | 8-K |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-statements, disclosure
TL;DR
Rezolute filed an 8-K on 4/28 for events on 4/25 - includes financials.
AI Summary
Rezolute, Inc. filed an 8-K on April 28, 2025, reporting on events that occurred on April 25, 2025. The filing is categorized under Regulation FD Disclosure and includes Financial Statements and Exhibits. Rezolute, Inc., formerly AntriaBio, Inc., is a pharmaceutical preparations company incorporated in Nevada.
Why It Matters
This 8-K filing provides updated financial information and disclosures for Rezolute, Inc., which is crucial for investors to assess the company's current financial health and strategic direction.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting financial statements and exhibits, not indicating any immediate material adverse events.
Key Players & Entities
- Rezolute, Inc. (company) — Registrant
- April 25, 2025 (date) — Earliest event date
- April 28, 2025 (date) — Filing date
- AntriaBio, Inc. (company) — Former company name
- Nevada (jurisdiction) — State of incorporation
FAQ
What is the primary purpose of this 8-K filing for Rezolute, Inc.?
The primary purpose is to provide a Regulation FD Disclosure and to file Financial Statements and Exhibits, with the earliest reported event date being April 25, 2025.
When was Rezolute, Inc. previously known by another name?
Rezolute, Inc. was formerly known as AntriaBio, Inc., with a name change date of January 14, 2013.
In which state is Rezolute, Inc. incorporated?
Rezolute, Inc. is incorporated in Nevada.
What is the business address of Rezolute, Inc.?
The business address is 275 Shoreline Drive, Suite 500, Redwood City, CA 94065.
What is the SIC code for Rezolute, Inc.?
The Standard Industrial Classification (SIC) code for Rezolute, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2025 regarding Rezolute, Inc. (RZLT).